Tag: Biotech
Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers
With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to ef...
The antibody drug conjugates market is projected to grow at an annualized rate of over 20%
Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.
The antibody drug conjugates market is estimated to be worth more than 15
Antibody drugconjugates (ADCs) represent a transformative approach to modern cancertreatment; over the years, this upcoming class of targeted therapeutic agentshas generated significant enthusiasm within the medical science community
The continuous manufacturing market- Roots Analysis
The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and restrictions imposed on distribution networks.
The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step.
The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for p
The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations.
Over 100 companies across the globe claim to provide contract fill / finish services (Rootsanalysis)
According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers.
The prefilled syringe fill / finish services market (Roots Analysis)
According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers.
The prefilled syringe fill / finish services market- RootsAnalysis
The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices.
Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique, either for in-house requirements or for contract service engagements, claims Roots Analysis
The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and restrictions imposed on distribution networks.
The “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030 - Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step.
The prefilled syringe fill / finish services market
Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.” For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/...
Drug repurposing service providers market is projected to grow at an annualized rate of 14.7% till 2030
Roots Analysis has done a detailedstudy on DrugRepurposing Service Providers Market, 2020-2030.” coveringkey aspects of the industry’s evolution and identifying potential future growthopportunities.
The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, - Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs
Global Collaborative Robots (Cobots) Market, 2020-2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”
